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Background: Earlobe arterialized capillary blood gas analysis can be used to estimate arterial gas content and may
be suitable for diagnosis and management of critically ill patients. However, its utility and applicability in the ICU
setting remains unexplored.
Methods: A prospective observational validation study was designed to evaluate this technique in a cohort of
mechanically ventilated adult critically ill patients admitted to a polyvalent ICU. Precision and agreement between
capillary gas measures and arterial references was examined. Acute Respiratory Distress Syndrome (ARDS) diagnosis
capabilities with the proposed technique were also evaluated. Finally, factors associated with sampling failure were
explored.
Results: Fifty-five patients were included into this study. Precision of capillary samples was high (Coefficient of
Variation PO2 = 9.8%, PCO2 = 7.7%, pH = 0.3%). PO2 measures showed insufficient agreement levels (Concordance
Correlation Coefficient = 0.45; bias = 12 mmHg; percentage of error = 19.3%), whereas better agreement was
observed for PCO2 and pH (Concordance Correlation Coefficient = 0.94 and 0.93 respectively; depreciable bias;
percentage of error 11.4% and 0.5% respectively). The sensitivity and specificity for diagnosing ARDS were 100%
and 92.3% using capillary gasometric measures. Sampling was unsuccessful in 43.6% of cases due to insufficient
blood flow. Age > 65 years was independently associated with failure (odds ratio = 1.6), however hemodynamic
failure and norepinephrine treatment were also influencing factors.
Conclusions: Earlobe capillary blood gas analysis is precise and can be useful for detecting extreme gasometrical
values. Diagnosis of ARDS can be done accurately using capillary measurements. Although this technique may be
insufficient for precise management of patients in the ICU, it has the potential for important benefits in the acute
phase of various critical conditions and in other critical care arenas, such as in emergency medicine, advanced
medical transport and pre-hospital critical care.
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The use of arterialized capillary blood from the earlobe
(EL) to estimate arterial blood gas content was first de-
scribed by Drs. Lilienthal and Riley [1]. This technique
is based on the hypothesis that blood from dilated capil-
laries of the EL contains a higher proportion of arterial
than venous blood and thus is a good estimator of arterial* Correspondence: svaquer@tauli.cat
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in any medium, provided the original work is pgas content. Sampling from the EL has several advantages
compared to arterial puncture such as reduced compli-
cation rate, minimized invasiveness and better patient tol-
erance. However, studies in healthy subjects and patients
have shown contradictory results on the accuracy of this
technique, which has limited its implementation in current
clinical practice [2-8]. As suggested in a recent meta-
analysis [9], arterial gasometrical values could be esti-
mated from EL capillary samples and may be useful for
clinical practice. However, limited precision was reported,an open access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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ences and a lack of standardized sampling procedures.
Rapid and reliable gasometric analytical capabilities are
of prime importance in critically ill patients and can be
determinants of diagnosis and treatment, such as in the
onset of Acute Respiratory Distress Syndrome (ARDS). EL
arterialized capillary blood gas analysis has the potential
for important benefits for critical care medicine in any of
its multiple arenas (ICU, advanced medical transport,
emergency medicine). However, limited information exists
on the utilization of this technique in critically ill patients.
We present a prospective observational validation study
to ascertain whether EL arterialized capillary blood gas
analysis, when collected with dedicated equipment and
procedures, can accurately estimate arterial gasometri-
cal values in critically ill patients and evaluate, directly
at point of care, its capability to diagnose ARDS when




Mechanically ventilated critically ill adult patients, with
an indwelling arterial line and admitted to the ICU for
either medical or surgical conditions, were eligible for
this study. Severe coagulopathy (prothrombin time > 2.5
ratio, platelet count < 10,000 units/dl) and inability to
obtain informed consent by the patient or next of kin
were exclusion criteria. Sample size estimation for com-
paring capillary versus arterial samples was based on the
method described by Walter and Shoukri [10,11]. In
order to compare the two methods using the Concord-
ance Correlation Coefficient (CCC) approach, a mini-
mum of 30 valid data points where needed. Due to an
unexpected high sampling failure ratio, 55 patients were
included in a non-consecutive fashion in order to obtain
31 valid samples. Two interim analyses were performed
after the inclusion of the 15th and 45th patients in order
to monitor sampling success, and to adjust patient inclu-
sion for the observed data acquisition rate and the re-
quired number of valid samples. The study protocol was
in accordance with the amended Declaration of Helsinki
and was approved by an Independent Ethics Committee
(IRB: 2009593. Comité Ètic d’Investigació Clínica, Corpor-
ació Sanitària Universitària Parc Taulí. Sabadell, Spain).
Procedures
Capillary sampling procedure was based on previous ex-
perience gathered in preliminary validation studies [12-14].
Two operators were trained on the procedures of the study
and performed all evaluations. EL arterialization, aim-
ing at inducing a capillary shunting between arterial
and venous territories, was achieved by applying a
vasodilation cream (2% nitro-glycerin cream - PharmacyDepartment, Corporació Sanitària Parc Taulí. Spain).
Arterialization was initially performed during two and a
half minutes for the first 20 patients, but was later in-
creased to five minutes for the remaining 35 patients of
the study. Reasons for increasing arterialization time were
based on the results from the first interim analysis in
which high sampling failure was observed. Increasing
arterialization time aimed at increasing capillary blood
flow at the earlobe in an attempt to improve sampling suc-
cess rate. Following arterialization, a dedicated collection
system (Earlobe Arterialized Blood Collector - EABC®;
Microgravity Center/FENG-PUCRS, Porto Alegre, Brazil)
was used for collection. Designed as a sterilized, self-
contained, small, portable device, the EABC® system
allowed anaerobic blood sampling by minimally trained
personnel with reduced discomfort to the subject. The
EABC® system consists of a plastic shell containing a
small blade, a heparinized capillary tube and a sensor
cartridge. After proper fixation to the EL, the sensor
cartridge receives arterialized blood directly from a
small cut in the skin through the capillary tube. Blood
was procured from a specific region of the earlobe in a
consistent fashion. The sensor cartridge and the capil-
lary tube are visible so that the operator can monitor
blood passage as it enters the cartridge until a prede-
fined mark. Samples were analyzed using CG4+ gasome-
trical cartridges and the i-STAT® portable analyzer
(Abbot, Abbott Park, IL, USA) [15]. Once patients were
included into the study, one blood sample was collected
per patient. Inability to obtain a valid blood sample after
four collection attempts was considered a sampling failure.
Simultaneously, an arterial blood sample was collected
from the arterial line and analyzed by the ABL 700® blood
gas analyzer (Radiometer, Brønshøj, Denmark) [16]. This
system was considered the reference method of measure
for this study. Both the i-STAT® and the ABL 700® were
calibrated, maintained and updated periodically as indi-
cated by the manufacturer.
Data collection
Common demographic variables and relevant clinical
variables were recorded (Table 1). We considered high heart
rate (> 130 beats per minute), low mean arterial pressure
(< 65 mmHg), low cardiac output index (< 2.5 L/min/m2)
measured by thermodilution techniques or by arterial pulse
contour analysis, increased lactate levels (> 22 mg/dl) and
vasoactive drug treatment, as markers of hemodynamic
failure. The main gasometrical variables pH, PO2, PCO2
and lactate were measured in arterial and EL arterialized
capillary samples.
Data analysis
Analytical performance and agreement between capillary
and arterial samples was evaluated using a combined




Age in years 63 (24 to 83)
Arterial hypertension 23 (41.8%)
Diabetes mellitus 19 (34.5%)
Chronic cardiac failure 4 (7.3%)
Severe vasculopathy 4 (7.3%)
Renal insufficiency 5 (9.1%)
Diagnostic at ICU admission
Severe sepsisa 21 (38.1%)
Respiratory failure 7 (12.7%)
Severe trauma 7 (12.7%)
Neurological 6 (10.8%)
Cardiogenic shock 5 (9.1%)
Miscellaneous 9 (16%)
Clinical variables
PEEP (cmH2O) 7.1 (4 to 12)
FiO2 0.36 (0.21 to 0.66)
Minute volume (L/min) 9 (5.5 to 19)
APACHE II 18.3 (3 to 34)
Mean arterial pressure (mmHg) 80 (57 to 113)
Cardiac index (L/min/m2) 3.2 (1 to 5.9)
Arterial lactate (mg/dl) 18.7 (6 to 71)
Arterial lactate > 22 mg/dl 10 (18%)
Sepsisa 32 (58.2%)
Platelets (× 103/dl) 226 (54 to 669)
Prothrombin time (ratio) 1.2 (1 to 1.9)
Prophylactic anticoagulant 40 (72.7%)
Antiplatelet treatment 6 (10.9%)
Vasoactive treatment 36 (65.5%)
NE 30 (83.3%)
NE dose (μg/kg/min) 0.49 (0.02 to 3.02)
Other vasoconstriction treatment 3 (8.2%)
Inotropic treatment 5 (13.8%)
Vasodilation treatment 2 (5.5%)
Data reported as mean (range), except where% is shown in which case values
illustrate ‘incidence’. APACHE II, Acute Physiology and Chronic Health
Evaluation II score; NE, norepinephrine; PEEP, positive end expiratory pressure.
aFollowing Surviving Sepsis Campaign Guidelines [17].
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slope of the regression line equation and the Bland-
Altman method [19]. Mean difference (bias), limits of
agreement of the mean difference (±2SD) and percent-
age of error (2SD/mean reference value) were calculated
to describe agreement levels of capillary measures with
the standard measure method (arterial samples + ABL700®). Precision of the new system was also evaluated
using the coefficient of variation (CV) approach (2SD/
mean) [20]. The lower CV, the higher precision of meas-
ure and a CV < 10% is desirable in order to enable valid
agreement evaluation between sampling/analysis tech-
niques. To this end, up to six samples were obtained
from one EL in five critically ill patients (mean = 3.8 (3
to 6) samples per patient). Precision of the reference sys-
tem (ABL 700®) when analyzing arterial samples is also
presented as provided by the producer [16].
The association between study variables and sampling
success/failure ratio was evaluated. The Chi-square test
was used for qualitative variables, two-tailed Student’s
paired t-test was used for quantitative variables and
Relative Risk (RR) was calculated for interpretation. Any
association of hemodynamic instability variables with
sampling failure was analyzed individually and in com-
bination using a linear-by-linear association test. Influ-
ence of vasoactive drugs, vasopressors and especially
norepinephrine (NE) was also evaluated. Threshold drug
dose for detecting an effect on sampling outcome was
determined by a Receiving Operator Curve (Sampling
success/Drug dose) and a Youden test [21]. Finally, a
multivariate analysis using logistic regression was per-
formed to find variables independently associated with
sampling failure.
ARDS was defined following the established criteria of
the Berlin definition [22]. Patients were classified in
three groups according to PaO2/FiO2 ratio (arterial PO2
divided by inspired O2 fraction): no-ARDS (PaO2/FiO2 >
300), mild (300 < PaO2/FiO2 > 200) or moderate - severe
(PaO2/FiO2 < 200). PaO2/FiO2 ratio was calculated in ar-
terial samples and was compared using a paired t-test.
Concordance of measures was evaluated using CCC.
Kappa coefficient was calculated to evaluate the agree-
ment between the two methods for classifying patients
in different groups. Finally, sensitivity and specificity for
diagnosing ARDS and moderate - severe ARDS using ca-
pillary samples was calculated.
Two-tailed significance threshold was established at
P < 0.05. Statistical analysis was performed using SPSS
version 19 statistical software (International Business
Machines. Armonk, NY, USA) and R Cran version 2.15 (R
Foundation for Statistical Computing. Vienna. Austria).
Results
Study patient characteristics were representative of a
common ICU patient population of a tertiary hospital
(Table 1). EL capillary blood samples were obtained in
56.4% (n = 31) of the cases. Precision levels of EL arteria-
lized capillary samples collected and analyzed using the
EABC® + i-STAT® system are presented in Table 2. Preci-
sion levels the ABL 700® system when analyzing arterial
samples were provided by the producer (Table 2).
Table 2 Precision analysis
Mean CV% (range)
Capillary + EABC®/i-STAT® Arterial + ABL 700®
PO2 9.8 (4.2 to 15.8) 4.3 (1.8 to 9.3)
pH 0.3 (0.2 to 0.4) 0.1 (0.08 to 0.1)
PCO2 7.7 (1 to 16.1) 3.1 (2 to 5.3)
Lactate 13.8 (3.8 to 21.1) 26.8 (4 to 66.6)a
CV, coefficient of variation.
aPrecision of in vitro lactate measures improves with increasing lactate
concentrations, therefore mean CV should be interpreted accordingly. At
blood lactate concentrations > 2 mmol/L/18 mg/dl, CV decreases below 10%.
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(CCC = 0.45; CI 95% = 0.26 to 0.6) with arterial samples.
Capillary measures underestimated arterial values with
a statistically significant mean difference of 12 mmHg
(P < 0.001) (Figure 1). This underestimation increased
the higher the patient arterial PO2 (slope = 0.54). The
accuracy of EL capillary blood measures was low as de-
termined by wide limits of agreement of the mean dif-
ference (± 15.5 mmHg) and high percentage of error
(19.3%). In a similar manner, PaO2/FiO2 values wereFigure 1 Differences between capillary and arterial measures. Bland-A
between earlobe arterialized capillary blood and arterial blood. X-axis: avera
arterialized capillary blood samples (EABC®/i-STAT®) and arterial samples (ABunderestimated (mean difference = 34.8; P < 0.001; CI
95% = 25.5 to 44) and the magnitude of this underestima-
tion increased the higher the arterial PaO2/FiO2 (slope =
0.74). Although PaO2/FiO2 calculation improved concor-
dance (CCC = 0.77; CI 95% = 0.64 to 0.86), measures pre-
sented a similar percentage of error (23.8%). On the
contrary, a good concordance was observed for PCO2
(CCC = 0.94; CI 95% = 0.89 to 0.97) without under or over-
estimation of values (Figure 1). The range of agreement of
the mean difference was ± 4.24 mmHg and the percentage
of error was 11.4%. Concordance was also good for pH
measures (CCC= 0.93; CI 95% = 0.85 to 0.96) but a statisti-
cally significant underestimation was found (mean diffe-
rence = 0.01 pH units; P < 0.001) (Figure 1). Nevertheless,
this error was systematic throughout the whole range of
values (slope = 0.99). In this case, the range of agreement of
the mean difference was ± 0.033 pH units and percentage
of error was 0.5%. Lactate measures also showed good con-
cordance (CCC= 0.96; CI 95% = 0.93 to 0.98), however
measures of arterialized EL blood were also underestimated
(mean difference = 1.07 mg/dl; P < 0.001) (Figure 1) but
again this error was systematic (slope = 0.97).ltman plots evaluating pH, PO2, PCO2 and lactate measure differences
ge arterial measure. Y-axis: mean difference between earlobe
L 700®) of each gasometric and lactate measure.
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the moment of inclusion. Patients were ventilated with a
mean PEEP of 8 cm H2O (4 to 15) and mean FiO2 0.37 (0.3
to 0.45), and presented a PaO2/FiO2 of 207 (113 to 299).
Sensitivity and specificity for diagnosing ARDS with EL
arterialized capillary samples were 100% and 92.3% respect-
ively. Patients were correctly classified into different severity
categories (no-ARDS, mild or moderate/severe ARDS;
Kappa coefficient = 0.85; P < 0.001). In patients with ARDS,
sensitivity and specificity for detecting moderate/severe pa-
tients (n = 10) were 100% and 75% respectively.
An increased sampling failure rate was evidenced in
this study (43.6%) compared to previous validation stud-
ies [12-14]. The most prevalent cause of sampling failure
was low blood delivery from the EL incision (78.1%).
This resulted in insufficient blood flow delivery to the
capillary tube, eventually leading to blood flow arrest be-
fore reaching the analysis cartridge. Insufficient blood
flow was easily detectable by the operator during sampling
procedure and was attributed to a reduced capillary flow
in the EL. Causes of reduced capillary perfusion were
therefore explored. Failure was more frequent in patients
older than 65 years (RR = 1.93, P = 0.04), in patients
treated with doses of NE > 0.22 μg/kg/min (RR = 2.37; P =
0.024) and in patients with diabetes mellitus (RR = 1.90
P = 0.03). Conversely, sampling success rate was 100% in
patients younger than 45 years old (n = 8). Univariate ana-
lysis showing no additional study variable was associated
with sampling outcome (Table 3). Higher failure rates were
observed in patients treated with vasoactive and vasocon-
strictor drugs. However, signs of hemodynamic instability
were not independently associated with sampling failure.
Linear-by-linear analysis showed an increase in sampling
failure the more variables were associated although statis-
tical significance was not reached (P = 0.146). IncreasingTable 3 Factors associated with sampling failure
Univariate analysis RR P (CI 95%)
Age > 65 years 1.9 0.04a (1 to 3.7)
Diabetes mellitus 1.9 0.03a (1.1 to 3.4)
Vasoactive treatment 2 0.06 (0.9 to 4.5)
Vasoconstrictor treatment 1.7 0.09 (0.8 to 3.5)
NE > 0.22 μg/kg/min 2.4 0.02a (1 to 5.7)
Sepsis 1.4 0.26 (0.7 to 2.7)
Lactate > 22 mg/dl 1.4 0.38 (0.7 to 3)
MAP (< 65 or > 90 mmHg) 0.8 0.57 (0.4 to 1.6)
Multivariate analysis OR P (CI 95%)
Age > 65 years 1.6 0.05a (0.99 to 2.6)
Diabetes mellitus 2.4 0.17 (0.7 to 8.2)
Vasoactive treatment 2.5 0.17 (0.7 to 8.9)
MAP, mean arterial pressure; NE, norepinephrine; OR, odds ratio; RR, relative risk.
aStatistically significant.vasodilation time from two and a half to five minutes did
not affect sampling success rate. Finally, multivariate ana-
lysis demonstrated that age was the only variable independ-
ently associated with sampling failure (Table 3).
Discussion
To our knowledge this validation study is the first to
evaluate analytical performance, diagnostic capabilities
and applicability of the EL arterialized capillary blood gas
analysis technique in a cohort of critically ill patients with
varied medical conditions and severity. Arterialized capil-
lary blood gas measurement from the EL has been exten-
sively evaluated in various physiological and pathological
situations. Nevertheless, contradictory results as to its ac-
curacy have been reported, especially for PO2 measures
[2-8]. In a recent meta-analysis authors reported that, al-
though agreement was not high (residual standard error
of 6 mmHg in PO2 measures), earlobe capillary estima-
tions could be used for clinical management since they
followed arterial values [9]. The main sources of variability
were attributed to different collection techniques and proce-
dures. Our results have evidenced a high level of precision
of capillary gasometrical analysis when a dedicated collector
and procedures are used to homogenize the collection tech-
nique (CV< 10% in all gasometrical variables - Table 2).
However, results from the present analysis demonstrate that
arterialized capillary blood is not a good estimator of arterial
PO2 values in critically ill patients due to poor concordance,
underestimation of values, wide limits of agreement and ele-
vated error in the measure. As previously reported, the
higher the arterial PO2 the higher the discrepancy between
capillary and arterial blood measures, which could be ex-
plained by poor arterialization and excessive venous blood
admixture [9]. Nevertheless, our findings remained un-
changed in spite of implementing a means for augmenting
EL arterio-venous capillary shunt (vasodilatation cream and
extended arterialization times). Adjusting for FiO2 values
(PaO2/FiO2) only improved concordance of measures, but
underestimation and significant percentage of error were
still present. This could be explained by a ‘normalization’
phenomenon when adjusting for FiO2 values in patients
with and without hypoxemia. Conversely, pH, PCO2 and
lactate measures were in good agreement with arterial sam-
ples over a wide range of values, provided an appropriate
offset was applied in some cases. Since arterio-venous
PCO2 differences are smaller, venous blood admixture may
have a reduced impact upon measures. Results showed
lactate measure precision was slightly above desirable
levels (CV = 13.8%) , however this could be attributable
to different analytical sensitivity of the equipment
used at different blood lactate levels. Precision of both
the i-STAT® and the ABL 700® systems measured in vitro
improves significantly at lactate levels > 18 mg/dl/2 mmol/L
(reported CV= 10% and 6.6% respectively).
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the accuracy of EL capillary blood gas analysis for pre-
dicting arterial values in the ICU environment [23], in
which PO2 agreement evaluation results were similar to
ours while PCO2 and pH measures showed good correl-
ation with the standard and were considered accurate
enough. Such disparity between the two studies may be
due to differences in population characteristics. In the
study of Honarmand and Safavi strict inclusion/exclusion
criteria reduced representativeness of its population by ex-
cluding patients with severe hemodynamic alterations,
high FiO2 or PEEP values, severe sepsis and multi-organ
failure [23]. Conversely, we included a broader spectrum
of patients to resemble a real population of critically ill
patients.
In patients admitted to the ICU, adequate manage-
ment often requires accurate gasometric evaluation (that
is for ventilator adjustment). Although precision of ca-
pillary samples was high, they did not yield a sufficient
level of agreement with the reference method in PO2
measures and presented excessive dispersion of mea-
sures for pH and PCO2 for this purpose (± 0.033 units
for pH and ± 4.24 mmHg for PCO2). Therefore, they
would not be recommended for its use in stable critical
patients admitted to the ICU and should not replace ar-
terial measurements. On the other hand, when extreme
gasometric values are present in the acute phase of
many critical conditions, such as in the onset of ARDS,
this level of inaccuracy becomes irrelevant. Accordingly,
this technique was capable of accurately detecting ex-
treme gasometrical values, and permitted diagnosis and
classification of patients presenting with severe respira-
tory failure and ARDS. In light of the present results, EL
capillary blood gas analysis should be considered for its
use for the initial diagnosis and emergency management
of critically ill patients when less accurate but easier and
faster techniques may be preferred. Furthermore, in situ-
ations where gasometric evaluation capabilities are not
easily available such as in pre-hospital critical care, ad-
vanced medical transport, and remote environments
medicine this technique can provide relevant informa-
tion to improve patient diagnosis and management with
potential benefits for patient outcome.
A second important finding of this study was a high
EL capillary sampling failure rate. This problem had not
been evidenced in preliminary validation studies [12-14]
and was considered to be independent from the new col-
lecting system. The two interim analyses, undertaken
after the inclusion of the 15th and 45th patients, permit-
ted the research team to survey sampling success evolu-
tion. High sampling failure ratios were evidenced early
in the present study and were clearly associated with in-
sufficient blood flow delivery to the collecting system.
This was attributed to a reduced capillary blood flow inthe EL. Thereafter, it was decided to increase arterialization
time in an attempt to increase vasodilation and augment
earlobe subcutaneous capillary blood flow. Nevertheless,
extended arterialization times were not able to compen-
sate for insufficient blood flow, and sampling failure
rates remained unchanged throughout the study. Upon
study finalization, data analysis showed that patient age
(> 65 years) was an independent factor associated with
sampling failure. Aging is responsible for vascular func-
tion impairment [24] and increased capillary rigidity,
which may cause limited capillary blood flow and blood
delivery to the collector. The impact of age became evi-
dent when patients aged < 45 years were analyzed, in
which case sampling success rate reached 100%. Indeed,
if proper patient selection is made a significant number
of patients could benefit from this technique. In our
polyvalent ICU, around 48% of patients admitted are <
65 years, representing more than 600 potential users of
this technique per year. Finally, vasoactive drugs, mod-
erate NE doses (> 0.22 μg/kg/min) and the cumulative
effect of hemodynamic failure variables were also factors
with potential influence upon sampling success; however,
data did not reach statistical significance. Interestingly,
signs of tissue hypoxia/hypoperfusion such as elevated
blood lactate or cutaneous signs of insufficient per-
fusion, and conditions known to cause microvascular
dysfunction such as sepsis [25] were not associated with
increased sampling failure ratios. This finding questions
the impact of low tissue perfusion associated with
hemodynamic instability as an influencing factor in
sampling success; however the present study was not
specifically designed to address this issue.
This study has a number of limitations that must be
taken into consideration. Firstly, the reduced number of
successful blood collections may be considered as a limi-
tation and could reduce validity of presented results.
Furthermore, the reduced number of patients presenting
with ARDS limited, and may have biased, the evaluation
of the diagnostic capability of capillary analyses of highly
altered gasometrical values. However, the study reached
the required statistical power to demonstrate concord-
ance of the methods being analyzed by the statistical ap-
proach selected. Secondly, although sampling failure was
attributed to patient characteristics, design problems
with the new collecting system could have influenced re-
sults. Nevertheless, the EABC® system and the i-STAT®
portable analyzer have already been used together satis-
factorily in several validation studies [12,14] where none
of the present problems could be detected. Thirdly, we
decided to include a broader spectrum of critically ill pa-
tients in order to improve representativeness of the data.
However, this complicated interpretation of results by
adding a number of uncontrolled variables, which could
have had an impact on the results. Finally, the utilization
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comparability. The ABL 700® system was the best gold-
standard system available, presenting adequate accuracy
and precision levels and allowing the research team to be
consistent with current analytical methodology used in our
ICU. On the other hand, the i-STAT® portable analyzer was
the only system that can be used with the collection system
used in this study (EABC®). Notwithstanding these limita-
tions, concordance levels achieved for pH, CO2 and lactate
values reported across collection and analysis techniques
were supportive of the fact that the type of analyzer used
did not influence results significantly.
Conclusion
This validation study suggests that EL arterialized capil-
lary blood gas analysis is precise, capable of detecting ex-
treme gasometric values in selected critically ill patients,
and could permit diagnosis and classification of patients
presenting with ARDS. Although it may present some
accuracy and applicability problems for accurate man-
agement of patients already admitted to the ICU, it
could be used for initial diagnosis and emergency man-
agement of critically ill patients. In medical scenarios
where less accurate but easier and faster techniques for
gasometric evaluation may be beneficial, or in situations
where no analytical capabilities are easily available, EL
arterialized capillary blood gas analysis at point-of-care
with dedicated sampling equipment and procedures can
offer significant advantages over traditional methods. In
light of these preliminary results, further investigation
should be considered in other critical care arenas, such
as in emergency medicine, advanced medical transport
and pre-hospital critical care where this technique could
offer decisive information with potential influence in pa-
tient outcome.
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